Accutane

Legal status and availability in the UK

In our online pharmacy, Accutane is available without a prescription, with discreet delivery to the United Kingdom in 9‑21 days.

Basic Accutane information

• INN (international nonproprietary name): Isotretinoin (13‑cis‑retinoic acid)
• Brand names available in the United Kingdom: Roaccutane; generic isotretinoin capsules
• ATC code: D10BA01
  • D10: Dermatologicals
  • D10B: Anti‑acne preparations
  • D10BA: Retinoids for treatment of acne
  • D10BA01: Isotretinoin
• Forms and strengths: oral capsules 5 mg, 10 mg, 20 mg, 40 mg
• Manufacturers in the United Kingdom: Mylan, Accord
• Registration status in the United Kingdom: Licensed (MHRA)
• OTC / Rx classification: Prescription only (Rx)

Clinical effectiveness in the UK

Do NHS patients actually get better and feel better after a course?

Within NHS dermatology services isotretinoin (INN: isotretinoin; ATC D10BA01) is the standard for severe, treatment‑resistant nodular acne.

Inflammatory lesion counts usually fall markedly across a 15–20‑week course, and quality of life typically improves during and after treatment.

Common challenges include lip and skin dryness, the monthly monitoring burden and the contraception checks for women of childbearing potential.

Discontinuation rates are driven mainly by intolerable dryness or biochemical abnormalities rather than life‑threatening events.

Prescribers balance cumulative dose targets (typically 120–150 mg/kg) against tolerability and some NHS centres favour lower continuous dosing to reduce side‑effects.

Indications and expanded uses — MHRA‑approved versus off‑label practice

Can isotretinoin be used for anything beyond severe nodular acne?

MHRA and SmPC guidance confines isotretinoin to severe recalcitrant nodular acne unresponsive to conventional therapies.

Dermatologists sometimes use isotretinoin off‑label for severe variants such as acne conglobata or aggressive scarring acne under specialist supervision.

Off‑label prescribing must be justified in the clinical record and the same monitoring precautions should apply.

Absolute constraints on use are grounded in teratogenicity and organ toxicity that demand strict prevention measures.

• MHRA‑approved indication: Severe recalcitrant nodular acne unresponsive to other treatments.
• Common off‑label indications: Treatment‑resistant acne conglobata, severe scarring acne under specialist care.

Before prescribing, clinicians typically:

• Confirm failure of oral antibiotics and topical therapy.
• Discuss teratogenic risk and contraception with women of childbearing potential.
• Arrange baseline LFTs, fasting lipids and pregnancy test where applicable and plan 4‑weekly monitoring.
• Document informed consent and rationale for off‑label use if chosen.

Composition and UK brand landscape — active ingredient, packaging and ATC

Which brands and strengths are available in the UK?

The active ingredient is isotretinoin (13‑cis‑retinoic acid), INN, ATC D10BA01.

In the UK, isotretinoin is supplied as Roaccutane and as generic capsules, for example from Mylan and Accord.

Capsule strengths commonly available are 5 mg, 10 mg, 20 mg and 40 mg.

Roche is the originator company.

Capsules are soft gelatin oral forms and should be taken with food to improve absorption.

Brands and strengths:

All isotretinoin products are prescription only and packaging differs by marketing authorisation holder though strengths are standardised.

Contraindications and special precautions — high‑risk groups and lifestyle restrictions

Who must never take isotretinoin and who needs extra care?

Absolute contraindications from the SmPC and MHRA include pregnancy, hypersensitivity to isotretinoin or excipients, severe hepatic or renal insufficiency, uncontrolled hyperlipidaemia and concurrent tetracyclines.

Relative precautions include current or past psychiatric disorders, diabetes, low bone mass and age under 12.

UK counselling routinely emphasises strict contraception for women of childbearing potential and avoidance of excessive alcohol.

Patients should be advised about skin fragility, increased photosensitivity and to stop and report any visual disturbance.

Key contraindications and precautions:

• Pregnancy: absolute contraindication (highly teratogenic).
• Tetracycline use: contraindicated due to raised risk of pseudotumour cerebri.
• Severe liver disease or uncontrolled lipids: avoid or monitor closely.

Monitoring by group:

Dosage guidelines — NHS‑recommended regimens and special population adjustments

How will my dose be chosen and how often will I be reviewed?

Standard dosing in adults and adolescents aged 12 and over is 0.5–1 mg/kg/day divided into two doses for a typical duration of 15–20 weeks.

The usual cumulative total is aimed at 120–150 mg/kg over the course.

Maximum dosing may reach up to about 2 mg/kg/day in selected refractory cases and repeat courses are only after at least 8 weeks off therapy.

Administration advice is to take capsules with food to enhance absorption.

Special population adjustments include avoiding routine use in children under 12 and starting low with cautious titration in the elderly or those with renal impairment.

Monitoring frequency is baseline LFTs, fasting lipids and pregnancy status where applicable and then normally at 4‑weekly intervals.

Dosing by weight band and monitoring schedule:

Interactions overview — drugs, food and Yellow Card reports

Which medicines and habits increase risk while taking isotretinoin?

Concurrent tetracyclines are contraindicated because of the risk of pseudotumour cerebri (benign intracranial hypertension).

Patients must avoid vitamin A supplements due to additive hypervitaminosis A effects.

Alcohol increases the risk of hepatotoxicity and may worsen triglyceride elevations so minimising intake is advised.

Isotretinoin is metabolised hepatically and clinicians should review other CYP‑interacting medicines for potential additive hepatotoxicity or lipid effects.

Interaction summary:

There is no established interaction with caffeine or tea.

Comparable medicines and prescribing preferences — alternatives in NHS practice

What are the standard alternatives before considering isotretinoin?

Before isotretinoin NHS pathways favour oral tetracyclines such as doxycycline or lymecycline, topical retinoids and benzoyl peroxide, and hormonal options for females including the combined oral contraceptive pill or anti‑androgens where appropriate.

Isotretinoin's pros are high cure and sustained remission rates for severe disease.

Its cons include teratogenicity, systemic adverse effects and the monitoring burden.

For moderate acne long antibiotic courses are increasingly avoided because of antimicrobial resistance concerns.

Pros and cons:

• Isotretinoin: High efficacy; strict monitoring and contraception requirements.
• Oral antibiotics: Useful for inflammatory acne but stewardship concerns limit long courses.
• Hormonal therapy: Effective for hormonally driven acne in females; not suitable for everyone.

NHS practice reserves isotretinoin for severe, recalcitrant nodular acne after other lines have failed.

Frequently asked questions

Q: Will isotretinoin permanently cure my acne?

A: Many patients achieve long‑term remission; relapse occurs in a minority and may be treated with a repeat course only after at least eight weeks off therapy.

Q: How does pregnancy prevention work in the UK?

A: Women of childbearing potential must follow a documented pregnancy prevention programme with reliable contraception (often two methods), negative pregnancy tests at baseline and monthly, and informed consent documented.

Q: What monitoring is routine?

A: Baseline then typically 4‑weekly checks for pregnancy where applicable, LFTs and fasting lipids, plus clinical review for mood or vision changes.

Q: Can I drink alcohol while taking isotretinoin?

A: You are advised to minimise alcohol because of potential additive effects on the liver and triglycerides.

Urgent actions:

• Contact your prescriber or local emergency service for severe mood change or visual disturbance.
• Stop the medicine and seek urgent review if pregnancy is suspected.

Guidelines for proper use — pharmacist counselling, NHS portals and support

What should the pharmacist tell me on collection?

Best practice counselling includes confirming identity and pregnancy status where relevant and explaining that capsules should be taken with food.

Advise on moisturisers and lip balms for cheilitis and instruct patients to avoid vitamin A supplements and tetracyclines.

Explain the monitoring schedule (baseline and monthly tests for pregnancy where applicable, LFTs and fasting lipids) and how to report side‑effects.

Documented consent and record‑keeping through NHS e‑records or clinic letters improves safety and continuity of care.

Signpost patients to NHS information and specialist nurse support and encourage Yellow Card reporting of suspected adverse reactions.

Pharmacist counselling checklist:

• Confirm pregnancy test status and contraception plan for women of childbearing potential.
• Give practical advice: take with food, use emollients and SPF, avoid excessive alcohol and vitamin A supplements.
• Provide a monitoring calendar: baseline bloods, then 4‑weekly tests and clinic reviews.

Monitoring calendar: baseline bloods and pregnancy test; Week 4: bloods and review; Repeat every 4 weeks until course end.

Delivery across the United Kingdom